Canadian Anesthesiologists’ Society 2019 Annual Meeting
2019 CAS Annual Meeting Dates: June 21-24, 2019 Where: Calgary, Alberta – Calgary TELUS Convention Centre Email: anesthesia@cas.ca Phone: 416 480 0602 Website: http://www.casconference.ca/en/ For Canadian anesthesiologists and colleagues from around the world, the CAS Annual Meeting provides an opportunity to be on the cutting edge of anesthesiology research, best practice, and hands-on learning experiences […] (March 1, 2019 @8:34 am)
2019 CAS Annual Meeting Dates: June 21-24, 2019 Where: Calgary, Alberta – Calgary TELUS Convention Centre Email: anesthesia@cas.ca Phone: 416 480 0602 Website: http://www.casconference.ca/en/ For Canadian anesthesiologists and colleagues from around the world, the CAS Annual Meeting provides an opportunity to be on the cutting edge of anesthesiology research, best practice, and hands-on learning experiences […] (March 1, 2019 @8:34 am)
2019 Visiting Professor Lecture – Dr. Eric Jacobsohn
Dr. Jacobsohn is a Professor in Departments of Anesthesiology, Pain and Perioperative Medicine, and in the Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba. (December 3, 2018 @11:58 am)
Dr. Jacobsohn is a Professor in Departments of Anesthesiology, Pain and Perioperative Medicine, and in the Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba. (December 3, 2018 @11:58 am)
2018 Visiting Professor Lecture – Dr. Philip Peng
Dr. Philip Peng is a full time professor in the Department of Anesthesia and Pain Management of University of Toronto. He is currently the director for Anesthesia Pain Management Center. He has played an important role in the education of pain medicine and established major teaching courses. Royal College of Physicians and Surgeons of Canada (RCPSC) honored him with Founder designation in Pain Medicine for his role in establishing Pain Medicine subspecialty in Canada. He is also a leader and pioneer in the application of ultrasound for pain medicine. He has edited 7 books and published more than 150 peer-reviewed and publications and book chapters. (October 25, 2018 @4:48 pm)
Dr. Philip Peng is a full time professor in the Department of Anesthesia and Pain Management of University of Toronto. He is currently the director for Anesthesia Pain Management Center. He has played an important role in the education of pain medicine and established major teaching courses. Royal College of Physicians and Surgeons of Canada (RCPSC) honored him with Founder designation in Pain Medicine for his role in establishing Pain Medicine subspecialty in Canada. He is also a leader and pioneer in the application of ultrasound for pain medicine. He has edited 7 books and published more than 150 peer-reviewed and publications and book chapters. (October 25, 2018 @4:48 pm)
Department of Anesthesiology, Pharmacology & Therapeutics Annual Report 2017
This year the report highlights a few areas in our department, with the usual detailed information placed as appendices. Please share with colleagues in your department, so they too can celebrate the successes of our colleagues as well as hopefully understand this diverse department a little better. (October 5, 2018 @4:38 pm)
This year the report highlights a few areas in our department, with the usual detailed information placed as appendices. Please share with colleagues in your department, so they too can celebrate the successes of our colleagues as well as hopefully understand this diverse department a little better. (October 5, 2018 @4:38 pm)
Department of Anesthesiology, Pharmacology & Therapeutics Seminar: Dr. Zheng Xie, M.D., Ph.D.
Tens of millions of patients worldwide, from newborn to elderly, receive anesthesia each year. The mechanisms of Anesthetics remain largely unresolved despite significant progress over the past several decades. Recently, evidence has been uncovered suggesting that anesthetics are neurotoxic to the developing brain in animals and possibly in humans. (September 24, 2018 @12:55 pm)
Tens of millions of patients worldwide, from newborn to elderly, receive anesthesia each year. The mechanisms of Anesthetics remain largely unresolved despite significant progress over the past several decades. Recently, evidence has been uncovered suggesting that anesthetics are neurotoxic to the developing brain in animals and possibly in humans. (September 24, 2018 @12:55 pm)
Research Day 2018 Guest Lecture – Dr Steven Schafer
The 2018 Anesthesiology, Pharmacology & Therapeutics Research Day 2018 Guest Lecture is available here “Clinical Pharmacology – A Journey from Michael Jackson to TensorFlow” Steven L. Shafer, MD Professor of Anesthesiology, Perioperative and Pain Medicine, Stanford University Adjunct Associate Professor of Bioengineering and Therapeutic Sciences, UCSF Dr. Shafer’s professional interests are the clinical pharmacology […] (June 21, 2018 @5:16 pm)
The 2018 Anesthesiology, Pharmacology & Therapeutics Research Day 2018 Guest Lecture is available here “Clinical Pharmacology – A Journey from Michael Jackson to TensorFlow” Steven L. Shafer, MD Professor of Anesthesiology, Perioperative and Pain Medicine, Stanford University Adjunct Associate Professor of Bioengineering and Therapeutic Sciences, UCSF Dr. Shafer’s professional interests are the clinical pharmacology […] (June 21, 2018 @5:16 pm)
Academic Gowning, Dr. Stephan Schwarz to Full Professor
The Department of Anesthesiology, Pharmacology & Therapeutics would like to congratulate Dr. Stephan Schwarz on becoming a full professor! (May 30, 2018 @4:10 pm)
The Department of Anesthesiology, Pharmacology & Therapeutics would like to congratulate Dr. Stephan Schwarz on becoming a full professor! (May 30, 2018 @4:10 pm)
APT Department Seminar: Pascal Bernatchez
Genetic aortopathies and muscular dystrophies are two seemingly unrelated groups of diseases with poor management options. Our laboratory has recently shown that cardiovascular medications that target the LDL-cholesterol synthesis pathways and the vasculature, particularly the endothelium, offer untapped therapeutic potential for patients afflicted by these conditions. Using classic and molecular pharmacology principles, we study how these medications mediate their unexpected effects and whether better treatments can be translated to the clinic. (May 22, 2018 @9:59 am)
Genetic aortopathies and muscular dystrophies are two seemingly unrelated groups of diseases with poor management options. Our laboratory has recently shown that cardiovascular medications that target the LDL-cholesterol synthesis pathways and the vasculature, particularly the endothelium, offer untapped therapeutic potential for patients afflicted by these conditions. Using classic and molecular pharmacology principles, we study how these medications mediate their unexpected effects and whether better treatments can be translated to the clinic. (May 22, 2018 @9:59 am)
Research Day 2018 Keynote speaker: Dr Steven Shafer
Dr. Shafer’s professional interests are the clinical pharmacology of intravenous anesthetic drugs, opioids and hypnotics used in anesthetic practice. However, his real passion is not the drugs themselves, but rather the mathematical models that characterize drug behavior. These include conventional pharmacokinetic and pharmacodynamic models, inverse models (used to drive target controlled infusion systems), Bayesian models (used to handle model uncertainty), pharmacokinetic and pharmacodynamic models of drug interaction, models of receptor function that help elucidate mechanisms of drug action, and models that relate drug response to "in silico" pharmacogenetics. (May 22, 2018 @10:00 am)
Dr. Shafer’s professional interests are the clinical pharmacology of intravenous anesthetic drugs, opioids and hypnotics used in anesthetic practice. However, his real passion is not the drugs themselves, but rather the mathematical models that characterize drug behavior. These include conventional pharmacokinetic and pharmacodynamic models, inverse models (used to drive target controlled infusion systems), Bayesian models (used to handle model uncertainty), pharmacokinetic and pharmacodynamic models of drug interaction, models of receptor function that help elucidate mechanisms of drug action, and models that relate drug response to "in silico" pharmacogenetics. (May 22, 2018 @10:00 am)